The stocks to follow tomorrow on the Paris Stock Exchange – Friday, April 8, 2022 – 04/07/2022 at 6:26 p.m.

(AOF) –

Akwel

Akwel lifted the veil Thursday evening on its 2021 results. Thus, the equipment supplier-systems supplier for the automotive industry generated a net profit (group share) of 51.2 million euros (-40.2% compared to to 2020) and current operating income of 75.2 million euros (-33.8% over one year), showing a margin of 8.2%, down 3.9 points. Turnover came to 922.5 million euros, down 1.6% on a reported basis, but up 2.8% at constant scope and exchange rates.

CNP Assurances

The Board of Directors of CNP Assurances met today to issue its reasoned opinion on the simplified public tender offer initiated by La Banque Postale (LBP) for the shares of CNP Assurances that it does not hold at price of 21.90 euros per share (dividend attached). The latter recommends, unanimously minus one abstention, that its shareholders tender their shares to LBP’s offer, judging it to be fair and in the interest of all stakeholders, be it the company, the shareholders or employees.

LDC

The LDC group achieved in 2021-2022 (financial year ended at the end of February) a turnover of 5.07 billion euros, up 14.5% over one year. This is the first time that the level of activity of the poultry specialist exceeds the symbolic bar of 5 billion. This includes growth of 16.1% in the fourth quarter to 1.4 billion euros. “As announced, the end-of-year celebrations went well and are generally in line with the Group’s expectations,” said the owner of the Loué and Le Gaulois brands.

Pherecydes Pharma

Pherecydes Pharma announces that Thibaut du Fayet, expert in the biotechnology sector, has joined the Management Board of Pherecydes Pharma as Chief Operating Officer. Thibaut du Fayet brings to the company a broad experience of more than 20 years in the pharmaceutical and life sciences industry. In 2008, he joined Transgene where he served for 13 years as Vice-President Development of partnerships, alliances and program management.

Osmozis

Osmozis recorded in the first half of 2021-2022, a turnover of 4.069 million euros, up 31%. “During the period, Osmozis’ full range of connected products and services continued to meet strong demand from campsite operators, amid a stabilizing health situation,” the company commented.

Leave a Replay